Thrombopoietin Levels and Platelet Transfusion in Neonates
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Infants who have low platelets and who require a platelet transfusion are included in this study. Platelet transfusions are routinely given to infants when their platelet count falls below a certain level. The study will look at the amount of platelets transfused. The purpose of the study is to evaluate the effect of platelet transfusions on the level of a protein (thrombopoietin) which is known to help control platelet production.
| Condition |
|---|
|
Thrombocytopenia |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Thrombopoietin Levels Following Platelet Transfusion in Neonates With Thrombocytopenia |
- Reduction in TPO levels following platelet transfusion [ Time Frame: Within 36 hours of transfusion ] [ Designated as safety issue: No ]
- Platelet rise following platelet transfusion in 10 mL/kg versus 15 mL/kg. [ Time Frame: Within 36 hours after platelet transfusion ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Blood samples were collected pre and post platelet transfusion. Samples included platelet count, thrombopoietin, and platelet factor 4.
| Enrollment: | 20 |
| Study Start Date: | May 2003 |
| Study Completion Date: | September 2004 |
| Primary Completion Date: | September 2004 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
10 mL/kg platelet transfusion
|
|
2
15 mL / kg platelet transfusion
|
Detailed Description:
Thrombocytopenia, defined as a platelet count < 150,000/mm3, is a very common hematologic problem in the neonatal period. Multiple etiologies are known to be associated with thrombocytopenia in neonates. Thrombopoietin (TPO) is known to be the central regulator of megakaryocyte and platelet production in adults and infants. However, the role of TPO in neonatal platelet regulation is not well understood. TPO levels have been shown to be higher in neonates with thrombocytopenia, with a decrease in TPO after resolution of the thrombocytopenia. The response of TPO levels in neonates after platelet transfusion has never been studied. In addition, the optimal volume of platelet transfusions has never been studied in neonates. This study will evaluate the response to 2 different volumes of platelet transfusion.
We hypothesize that a decrease in plasma TPO levels will be seen following a platelet transfusion in a population of neonates with thrombocytopenia. We also hypothesize that a platelet transfusion of 15 mL/kg will result in a greater rise in platelet count than a transfusion pf 10 mL/kg of platelets.
Eligibility| Ages Eligible for Study: | up to 6 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Infants who require platelet transfusion
Inclusion Criteria:
- Preterm infants with thrombocytopenia
- Decision made by medical team to transfuse with platelets
Exclusion Criteria:
- Infants with major congenital malformations
Contacts and Locations| United States, Delaware | |
| Christiana Hospital | |
| Newark, Delaware, United States, 19718 | |
| Principal Investigator: | Alex Kline, MD | Christiana Hospital |
| Principal Investigator: | David A. Paul, MD | Christiana Hospital |
More Information
No publications provided
| Responsible Party: | T. Alex Kline, Christiana Hospital |
| ClinicalTrials.gov Identifier: | NCT00549484 History of Changes |
| Other Study ID Numbers: | CCC#23049 |
| Study First Received: | October 24, 2007 |
| Last Updated: | January 16, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Christiana Care Health Services:
|
Thrombocytopenia Thrombopoietin Platelet Transfusion Platelet Factor 4 |
Additional relevant MeSH terms:
|
Thrombocytopenia Blood Platelet Disorders Hematologic Diseases |
ClinicalTrials.gov processed this record on May 21, 2013